Skip to main content
. 2011 Jun 28;11:79. doi: 10.1186/1471-2377-11-79

Table 1.

Reasons for study discontinuation

Reason PS-DHA Placebo
Protocol violation 2 1

Withdrawn consent 5 6

Adverse events* 5 5

Severe adverse events** 1# 1##

Sum 13 13

* Adverse events are specified in Table 6

** Classified by the study physician as not related to the study treatment

# Hospitalization due to hyponatremia

## Hospitalization due to atrial fibrillation and epigastric pain